Literature DB >> 23962873

Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms.

A Amendola1, A Butera1, M Sanchez2, W Strober3, M Boirivant1.   

Abstract

On the basis of previous studies demonstrating that a breach of the colonic epithelial barrier is associated with a microbiota-dependent increase in lamina propria (LP) regulatory cells, we investigated if the lack of spontaneous intestinal inflammation observed in nucleotide-binding oligomerization domain 2 (Nod2)-/- mice was due to enhanced intestinal regulatory function. We found that the LP CD4+ T-cell population of Nod2-/- mice contains an increased percentage of CD4+ regulatory T cells bearing transforming growth factor -β/latency peptide (LP CD4+LAP (latency-associated peptide) + T cells) both under baseline conditions and following an intentional breach of the colonic barrier induced by ethanol administration. In addition, we found that Nod2-/- mice manifest decreased severity of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-colitis and that TNBS-colitis in Nod2-/- or Nod2+/+ mice is ameliorated by adoptive transfer of LP cells from ethanol-treated mice before, but not after, depletion of LAP+ T cells. This increased regulatory T-cell response in Nod2-/- mice could explain why NOD2 polymorphisms in humans are not in themselves sufficient to establish inflammatory lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23962873      PMCID: PMC4778708          DOI: 10.1038/mi.2013.58

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  36 in total

1.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome.

Authors:  Christian Bauer; Peter Duewell; Christine Mayer; Hans Anton Lehr; Katherine A Fitzgerald; Marc Dauer; Jurg Tschopp; Stefan Endres; Eicke Latz; Max Schnurr
Journal:  Gut       Date:  2010-05-04       Impact factor: 23.059

2.  Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset.

Authors:  Roopali Gandhi; Mauricio F Farez; Yue Wang; Deneen Kozoriz; Francisco J Quintana; Howard L Weiner
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

3.  Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches.

Authors:  Frédérick Barreau; Chrystèle Madre; Ulrich Meinzer; Dominique Berrebi; Monique Dussaillant; Françoise Merlin; Lars Eckmann; Mickael Karin; Ghislaine Sterkers; Stéphane Bonacorsi; Thécla Lesuffleur; Jean-Pierre Hugot
Journal:  Gut       Date:  2009-10-15       Impact factor: 23.059

4.  Induction of intestinal Th17 cells by segmented filamentous bacteria.

Authors:  Ivaylo I Ivanov; Koji Atarashi; Nicolas Manel; Eoin L Brodie; Tatsuichiro Shima; Ulas Karaoz; Dongguang Wei; Katherine C Goldfarb; Clark A Santee; Susan V Lynch; Takeshi Tanoue; Akemi Imaoka; Kikuji Itoh; Kiyoshi Takeda; Yoshinori Umesaki; Kenya Honda; Dan R Littman
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

5.  A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis.

Authors:  Monica Boirivant; Antonello Amendola; Alessia Butera; Massimo Sanchez; Lili Xu; Mariarosaria Marinaro; Atsushi Kitani; Claudia Di Giacinto; Warren Strober; Ivan J Fuss
Journal:  Gastroenterology       Date:  2008-08-05       Impact factor: 22.682

6.  Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.

Authors:  I D Iliev; E Mileti; G Matteoli; M Chieppa; M Rescigno
Journal:  Mucosal Immunol       Date:  2009-04-22       Impact factor: 7.313

7.  Chronic stimulation of Nod2 mediates tolerance to bacterial products.

Authors:  Matija Hedl; Jing Li; Judy H Cho; Clara Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

8.  Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells.

Authors:  Annamaria Pronio; Chiara Montesani; Cinzia Butteroni; Simona Vecchione; Gloria Mumolo; AnnaRita Vestri; Domenico Vitolo; Monica Boirivant
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

9.  NOD2 regulates hematopoietic cell function during graft-versus-host disease.

Authors:  Olaf Penack; Odette M Smith; Amy Cunningham-Bussel; Xin Liu; Uttam Rao; Nury Yim; Il-Kang Na; Amanda M Holland; Arnab Ghosh; Sydney X Lu; Robert R Jenq; Chen Liu; George F Murphy; Katharina Brandl; Marcel R M van den Brink
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

10.  CARD15/NOD2 is required for Peyer's patches homeostasis in mice.

Authors:  Frédérick Barreau; Ulrich Meinzer; Fabrice Chareyre; Dominique Berrebi; Michiko Niwa-Kawakita; Monique Dussaillant; Benoit Foligne; Vincent Ollendorff; Martine Heyman; Stéphane Bonacorsi; Thecla Lesuffleur; Ghislaine Sterkers; Marco Giovannini; Jean-Pierre Hugot
Journal:  PLoS One       Date:  2007-06-13       Impact factor: 3.240

View more
  22 in total

1.  The interplay between microbes and the immune response in inflammatory bowel disease.

Authors:  Ashleigh Goethel; Kenneth Croitoru; Dana J Philpott
Journal:  J Physiol       Date:  2018-07-17       Impact factor: 5.182

2.  In vivo inhibition of RIPK2 kinase alleviates inflammatory disease.

Authors:  Justine T Tigno-Aranjuez; Pascal Benderitter; Frederik Rombouts; Frederik Deroose; XiaoDong Bai; Benedetta Mattioli; Fabio Cominelli; Theresa T Pizarro; Jan Hoflack; Derek W Abbott
Journal:  J Biol Chem       Date:  2014-09-11       Impact factor: 5.157

3.  NOD2 is dispensable for ATG16L1 deficiency-mediated resistance to urinary tract infection.

Authors:  Caihong Wang; Xuejun Yuan; Emily Ma; Graziella R Mendonsa; Theo S Plantinga; Lambertus A Kiemeney; Sita H Vermeulen; Indira U Mysorekar
Journal:  Autophagy       Date:  2013-12-18       Impact factor: 16.016

4.  An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitis.

Authors:  Tetsuya Takagawa; Atsushi Kitani; Ivan Fuss; Beth Levine; Steven R Brant; Inga Peter; Masaki Tajima; Shiro Nakamura; Warren Strober
Journal:  Sci Transl Med       Date:  2018-06-06       Impact factor: 17.956

5.  Understanding the development and function of the gut microbiota in health and inflammation.

Authors:  Deepak Selvakumar; Dolan Evans; Katharine Z Coyte; John McLaughlin; Andy Brass; Laura Hancock; Sheena Cruickshank
Journal:  Frontline Gastroenterol       Date:  2022-06-15

6.  Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.

Authors:  Antonella D'Ambrosio; Andrea Cossu; Antonello Amendola; Alessandro Zandri; Alessia Butera; Massimo Sanchez; Mauro Biffoni; Annamaria Pronio; Chiara Montesani; Anna Kohn; Roberta Pica; Monica Boirivant
Journal:  J Crohns Colitis       Date:  2015-11-20       Impact factor: 9.071

7.  Experimental Models of Inflammatory Bowel Diseases.

Authors:  Patricia Kiesler; Ivan J Fuss; Warren Strober
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-03-01

8.  Reactive oxygen species regulate caspase-11 expression and activation of the non-canonical NLRP3 inflammasome during enteric pathogen infection.

Authors:  Christopher R Lupfer; Paras K Anand; Zhiping Liu; Kate L Stokes; Peter Vogel; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  PLoS Pathog       Date:  2014-09-25       Impact factor: 6.823

9.  Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths.

Authors:  K A Smith; K J Filbey; L A Reynolds; J P Hewitson; Y Harcus; L Boon; T Sparwasser; G Hämmerling; R M Maizels
Journal:  Mucosal Immunol       Date:  2015-08-19       Impact factor: 7.313

Review 10.  Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease.

Authors:  P J Basso; M T C Fonseca; G Bonfá; V B F Alves; H Sales-Campos; V Nardini; C R B Cardoso
Journal:  Braz J Med Biol Res       Date:  2014-07-25       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.